{"DataElement":{"publicId":"2646439","version":"1","preferredName":"Kaposi Sarcoma Malignant Neoplasm Cutaneous Assessment Status","preferredDefinition":"the status of cutaneous malignant neoplasms (lesions) in Kaposi Sarcoma.","longName":"KS_MNEO_C_ASESS_STAT","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2640029","version":"1","preferredName":"Kaposi Sarcoma Malignant Neoplasm Cutaneous Assessment","preferredDefinition":"information relating to an assessment of cutaneous malignant neoplasms (lesions) in Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells).","longName":"KS_MLGNEO_CUT_ASSESS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2640017","version":"1","preferredName":"Kaposi Sarcoma Malignant Neoplasm","preferredDefinition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin however, it may also occur internally.  It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C9087:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kaposi Sarcoma","conceptCode":"C9087","definition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"30FA69F5-9B59-3F85-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-21","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-05-21","modifiedBy":"ONEDATA","dateModified":"2007-05-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2646195","version":"1","preferredName":"Cutaneous Assessment","preferredDefinition":"(kyoo-TAY-nee-us) Having to do with the skin.:The final result of a determination of the value, significance, or extent of.","longName":"C13316:C25367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous","conceptCode":"C13316","definition":"Involving the skin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25367","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"31D6E6C7-F1F1-0CAB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-01","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-01","modifiedBy":"ONEDATA","dateModified":"2007-06-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"30F9D0A4-8A58-4583-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-12-09","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-05-21","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2646440","version":"1","preferredName":"Kaposi Sarcoma Malignant Neoplasm Cutaneous Assessment Status","preferredDefinition":"the status of cutaneous malignant neoplasms (lesions) in Kaposi Sarcoma.","longName":"KS_MNEO_C_ASESS_STAT","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"80","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Since baseline, >=50% of raised have become flat","valueDescription":"Since baseline, >=50% of raised have become flat","ValueMeaning":{"publicId":"2646441","version":"1","preferredName":"Since baseline, >=50% of raised have become flat","longName":"2646441","preferredDefinition":"Since baseline, >=50% of raised have become flat","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"31EF0D20-6522-0B4E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"31EF0EBB-8E89-0C5F-E044-0003BA3F9857","beginDate":"2007-06-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-02","modifiedBy":"ONEDATA","dateModified":"2007-06-02","deletedIndicator":"No"},{"value":"None of the above","valueDescription":"None of the above","ValueMeaning":{"publicId":"2577583","version":"1","preferredName":"None of the above","longName":"2577583v1.00","preferredDefinition":"None of the choices above are suitable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None of the Above","conceptCode":"C133298","definition":"None of the choices above are suitable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FC1C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-07","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-02-07","modifiedBy":"KUMMEROA","dateModified":"2023-09-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"31EF0EBB-8EA0-0C5F-E044-0003BA3F9857","beginDate":"2007-06-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-02","modifiedBy":"ONEDATA","dateModified":"2007-06-02","deletedIndicator":"No"},{"value":">=25% increase in the number of raised lesions","valueDescription":">=25% increase in the number of raised lesions","ValueMeaning":{"publicId":"3115749","version":"1","preferredName":">=25% increase in the number of raised lesions","longName":"3115749","preferredDefinition":">=25% increase in the number of raised lesions","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A436A18-3A02-2C9C-E040-BB89AD43650B","latestVersionIndicator":"Yes","beginDate":"2010-06-30","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-06-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A436A18-3A1B-2C9C-E040-BB89AD43650B","beginDate":"2010-06-30","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-06-30","modifiedBy":"ONEDATA","dateModified":"2010-06-30","deletedIndicator":"No"},{"value":">=25% increase in the total number of raised lesions or a minimum of 5 new raised lesions, whichever is greater, either whole body, or in the case of participants with > 50 lesions at entry, in the combined representative areas","valueDescription":">=25% increase in the total number of raised lesions or a minimum of 5 new raised lesions, whichever is greater, either whole body, or in the case of participants with > 50 lesions at entry, in the combined representative areas","ValueMeaning":{"publicId":"7372094","version":"1","preferredName":">=25% increase in the total number of raised lesions or a minimum of 5 new raised lesions, whichever is greater, either whole body, or in the case of participants with > 50 lesions at entry, in the combined representative areas","longName":"7372094","preferredDefinition":">=25% increase in the total number of raised lesions or a minimum of 5 new raised lesions, whichever is greater, either whole body, or in the case of participants with > 50 lesions at entry, in the combined representative areas","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB81F11F-025E-2F96-E053-4EBD850A7C0A","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AB81F11F-0277-2F96-E053-4EBD850A7C0A","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","deletedIndicator":"No"},{"value":"<25% increase in the number of raised lesions compared to baseline or best response","valueDescription":"<25% increase in the number of raised lesions compared to baseline or best response","ValueMeaning":{"publicId":"7372095","version":"1","preferredName":"<25% increase in the number of raised lesions compared to baseline or best response","longName":"7372095","preferredDefinition":"<25% increase in the number of raised lesions compared to baseline or best response","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB81F11F-0281-2F96-E053-4EBD850A7C0A","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AB81F11F-029A-2F96-E053-4EBD850A7C0A","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","deletedIndicator":"No"},{"value":"<50% of raised lesions have become flat","valueDescription":"<50% of raised lesions have become flat","ValueMeaning":{"publicId":"7372096","version":"1","preferredName":"<50% of raised lesions have become flat","longName":"7372096","preferredDefinition":"<50% of raised lesions have become flat","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB81F11F-02A4-2F96-E053-4EBD850A7C0A","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AB81F11F-02BD-2F96-E053-4EBD850A7C0A","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","deletedIndicator":"No"},{"value":">=50% of raised lesions have become flat","valueDescription":">=50% of raised lesions have become flat","ValueMeaning":{"publicId":"7372097","version":"1","preferredName":">=50% of raised lesions have become flat","longName":"7372097","preferredDefinition":">=50% of raised lesions have become flat","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB81F11F-02C7-2F96-E053-4EBD850A7C0A","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AB81F11F-02E0-2F96-E053-4EBD850A7C0A","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","deletedIndicator":"No"},{"value":"Complete resolution of any detectable residual disease","valueDescription":"Complete resolution of any detectable residual disease","ValueMeaning":{"publicId":"7372078","version":"1","preferredName":"Complete resolution of any detectable residual disease","longName":"7372078","preferredDefinition":"Complete resolution of any detectable residual disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB81E05F-3599-30E5-E053-4EBD850A6C5C","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AB81F11F-02EA-2F96-E053-4EBD850A7C0A","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2404650","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"005AD6E5-057F-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"31EDFC0F-197B-0B4C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-02","modifiedBy":"CAMPBELB","dateModified":"2020-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"7283431","version":"1","longName":"CRF CDEs","context":"AMC","ClassificationSchemeItems":[{"publicId":"7312662","version":"1","longName":"KS","context":"AMC"}]}],"AlternateNames":[{"name":"AMC","type":"USED_BY","context":"AMC"},{"name":"RESP_CUTLES","type":"OID, AMC","context":"AMC"}],"ReferenceDocuments":[{"name":"Character of cutaneous lesions","type":"Preferred Question Text","description":"Character of cutaneous lesions","url":null,"context":"CTEP"}],"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"31EDFC0F-195D-0B4C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-02","modifiedBy":"COLLIED","dateModified":"2020-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}